Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #3
We have updated the Canadian Rheumatology Association (CRA) guidelines for rheumatoid arthritis (RA) with a significant addition and expansion to an existing recommendation addressing the dose reduction/tapering and discontinuation of disease-modifying antirheumatic drugs (DMARDs). New recommendations now encompass conventional synthetic, targeted synthetic, and biologic DMARDs.
Authors
- Jordi Pardo Pardo (ORCID: https://orcid.org/0000-0002-3985-5335)
- Peter Tugwell (ORCID: https://orcid.org/0000-0001-5062-0556)
- Glen Hazlewood (ORCID: https://orcid.org/0000-0001-7709-3741)
- Dawn P. Richards (ORCID: https://orcid.org/0000-0003-1151-0826)
- Shahin Jamal (ORCID: https://orcid.org/0000-0001-5870-3567)
- R M Taylor-Gjevre
- Orit Schieir (ORCID: https://orcid.org/0000-0002-5217-9028)
- Laurie Proulx (ORCID: https://orcid.org/0000-0003-1656-0371)
- Pooneh Akhavan (ORCID: https://orcid.org/0000-0003-1882-7420)
- Bindee Kuriya (ORCID: https://orcid.org/0000-0003-3370-0006)
- Alexandra Legge (ORCID: https://orcid.org/0000-0003-0373-4985)
- Roko P.A. Nikolic (ORCID: https://orcid.org/0000-0003-4199-733X)
- Claire E.H. Barber
- Hugues Allard-Chamard
- J. Carter Thorne
- Janet E. Pope
- Arnav Agarwal
- Cheryl Barnabe
Institutions
- Western University (CA)
- Mount Sinai Hospital (CA)
- Dalhousie University (CA)
- Université de Sherbrooke (CA)
- University of Ottawa (CA)
- University of Calgary (CA)
- University of Saskatchewan (CA)
- Canadian Rheumatology Association (CA)
- Research Canada (CA)
- Arthritis Research Centre of Canada (CA)
- Canadian Arthritis Patient Alliance (CA)
- Cochrane (CA)
- Hamilton Health Sciences (CA)
Publication Details
- Journal
- The Journal of Rheumatology
- Published
- 2026-04-01
- DOI
- https://doi.org/10.3899/jrheum.2026-0228
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amgen
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Sanofi
- F. Hoffmann-La Roche
- Therakos
- Canadian Rheumatology Association
- Celltrion
- Swedish Orphan Biovitrum